Alessandra Faccin Assis - Jul 25, 2025 Form 4 Insider Report for ASHLAND INC. (ASH)

Role
SVP and GM, Life Sciences
Signature
/s/ Serena S. Kenost, Attorney-in-Fact for Alessandra Faccin Assis
Stock symbol
ASH
Transactions as of
Jul 25, 2025
Transactions value $
$92,063
Form type
4
Date filed
7/28/2025, 04:30 PM
Previous filing
Feb 3, 2025
Next filing
Nov 17, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Assis Alessandra Faccin SVP and GM, Life Sciences 8145 BLAZER DRIVE, WILMINGTON /s/ Serena S. Kenost, Attorney-in-Fact for Alessandra Faccin Assis 2025-07-28 0001931500

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASH Common Stock Options Exercise $160K +3.12K +99.14% $51.26 6.27K Jul 25, 2025 Direct F1
transaction ASH Common Stock Tax liability -$68K -1.33K -21.15% $51.26 4.95K Jul 25, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASH Restricted Stock Unit Options Exercise $0 -3.12K -19.99% $0.00 12.5K Jul 25, 2025 Common Stock 3.12K Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance includes additional restricted stock units acquired in lieu of cash dividends.
F2 Payment of tax liability by withholding securities incident to the vesting of Restricted Stock Units acquired pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3.
F3 Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.
F4 On July 25, 2024, the Reporting Person was granted 15,234 restricted stock units, vesting over a three-year period, with 20% vesting on July 25, 2025, 20% vesting on July 25, 2026, and 60% vesting on July 25, 2027, provided that the Reporting Person remains in continuous employment with the Issuer.